|
Fri, 03/28/2025 - 18:00 |
Sturdy Health and Dana-Farber Cancer Institute Collaborate to Transform Cancer Care in Local Community |
Dana Farber |
|
Fri, 03/28/2025 - 17:59 |
Vish Viswanath, PhD, of Dana-Farber Cancer Institute elected as Fellow of the American Association for the Advancement of Science |
Dana Farber |
|
Mon, 03/10/2025 - 23:33 |
Red Sox pitcher Garrett Whitlock named 2025 Jimmy Fund Captain |
Dana Farber |
|
Wed, 02/12/2025 - 22:51 |
Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem Meetings |
Dana Farber |
|
Mon, 01/27/2025 - 17:40 |
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence |
Dana Farber |
|
Tue, 07/23/2024 - 19:15 |
Dana-Farber's Edward Chouchani selected as a Howard Hughes Medical Institute Investigator |
Dana Farber |
|
Thu, 06/27/2024 - 23:50 |
Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds |
Dana Farber |
|
Fri, 06/07/2024 - 11:27 |
Dana-Farber Cancer Institute receives $10 million gift from the Ge Li & Ning Zhao Family Foundation |
Dana Farber |
|
Wed, 02/28/2024 - 18:40 |
Laurie H. Glimcher, MD, selected for STAT's 2024 STATUS List |
Dana Farber |
|
Wed, 01/02/2019 - 20:14 |
More than 115 Dana-Farber-affiliated physicians recognized as Top Doctors |
Dana Farber |
|
Wed, 12/19/2018 - 17:58 |
Neoantigen vaccine spurs immune response in glioblastoma |
Dana Farber |
|
Tue, 12/18/2018 - 18:34 |
Prostate cancer scoring method may underestimate mortality risk in black men |
Dana Farber |
|
Tue, 12/18/2018 - 10:42 |
James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute |
Dana Farber |
|
Sun, 12/16/2018 - 22:46 |
Celgene Corporation Announces Celgene Cancer Care Links Program Grant Recipients |
BMS |
|
Fri, 12/14/2018 - 06:10 |
Mapping cancer resistance workarounds, probing promoters in autism, profiling microbes' metabolism in IBD, and more. |
Broad Institute |
|
Thu, 12/13/2018 - 17:00 |
Exercise-related hormone irisin found to target key bone cells |
Dana Farber |
|
Tue, 12/11/2018 - 19:01 |
Study shows PARP inhibitor drugs rouse immune system attack on some ovarian cancers |
Dana Farber |
|
Mon, 12/10/2018 - 07:37 |
HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer |
Broad Institute |
|
Fri, 12/07/2018 - 18:18 |
Ann Partridge honored as the 2018 AACR Outstanding Investigator for Breast Cancer Research |
Dana Farber |
|
Fri, 12/07/2018 - 17:01 |
New research from Dana-Farber highlights quality-of-life issues facing breast cancer survivors following surgery |
Dana Farber |
|
Wed, 12/05/2018 - 17:26 |
Eric Winer, MD awarded the 2018 Susan G. Komen Brinker Award for Scientific Distinction in Clinical Research |
Dana Farber |
|
Mon, 12/03/2018 - 19:11 |
Dana-Farber scientists to present new research on improving outcomes in stem cell transplantation for myeloid cancers |
Dana Farber |
|
Mon, 12/03/2018 - 16:59 |
Dana-Farber scientists to present research on myeloma progression from precursor conditions and novel approaches to treatment |
Dana Farber |
|
Mon, 12/03/2018 - 06:32 |
Geron Reports Updated Results from Phase 2 Portion of IMerge at the 60th American Society of Hematology Annual Meeting |
Geron |
|
Mon, 12/03/2018 - 02:33 |
ASH 2018 Day 3: Novel Proteasome Inhibitors Update |
MMRF |
